Landmark integration of in vitro organ-on-a-chip and computational modeling marks a pivotal advancement in disease simulation, drug testing, and personalized medicine....
New patent strengthens global IP portfolio for noninvasive lung cancer detection platform, expanding bioAffinity’s reach into international markets ...
Danish multicenter study confirms clinical utility of genomic test in identifying low-risk stage I–II melanoma patients, advancing precision in surgical decision-making ...
New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy...
Innovative device designed to maintain sinus patency post-surgery, enhancing healing and patient comfort without the need for removal...
New global report explores the transformative role of digital platforms, AI, and connectivity in reshaping surgical precision, training, and patient outcomes across healthcare systems....
NDA for TAR-200 targets high-risk non-muscle invasive bladder cancer, highlighting potential to transform treatment for patients unresponsive to BCG therapy...
Renowned oncology expert joins to support advancement of next-generation cancer diagnostics and therapeutics....
The NMPA approval of the ZEISS CLARUS 700 represents a major leap forward in ultra-widefield retinal imaging, offering high-resolution, true color visualization to support early detection and management of complex eye diseases across China....
Next-Generation Oscillating System Enhances Precision and Protects Delicate Tissue in Spine and Cranial Procedures...
